The in vivo activity of glutamate dehydrogenase (GDH) in the direction of reductive amination was measured in rat brain at steady-state concentrations of brain ammonia and glutamate after intravenous infusion of the substrate 15 This mitochondrial enzyme is present at a high level in rat brain, with an in vitro activity of 900 mol/h/g (1). GDH is believed to contribute to the synthesis of the metabolic and neurotransmitter pools of glutamate. While glutamine is also an important precursor of the neurotransmitter glutamate (2-4), there is evidence to suggest that the glutamate-glutamine cycle is not operating in a stoichiometric manner (5), and some de novo synthesis of glutamate from glucose is required to maintain the neurotransmitter pool (5, 6). GDH is a likely candidate for this role, since the equilibrium of the reaction favors the formation of glutamate.While GDH activities measured in cultured astrocytes and synaptosomal preparations have provided useful information (7-9), it is also important to measure the activity in intact brain, because the distribution of this enzyme according to cell type is controversial. Biochemical and histochemical studies show higher GDH levels in neurons (10 -12), while immunocytochemical studies show highest GDH immunoreactivity in astrocytes (13) N]glutamine were quantified in vitro for better spectral resolution. The results are discussed in relation to the role of GDH in glutamate replenishment. An explanation is offered for the apparent discrepancy between results obtained with labeled glucose and ammonia on the role of GDH in glutamate synthesis.
EXPERIMENTAL PROCEDURESAnimal Preparation and Ammonia Infusion-Male Wistar rats (250 -300 g) were anesthetized by the intraperitoneal injection of sodium pentobarbital (Nembutal; 40 mg/kg body weight), and prepared for ammonia infusion through the femoral vein (21). Two infusion protocols were used to achieve different steady-state brain ammonia concentrations for measurement of in vivo GDH activities. One group of rats (Group I) was given infusion of 15 NH 4 Cl (Cambridge Isotopes: Ͼ97% enriched in 15 N in 1 M aqueous solution at pH 7.4) at a rate of 2.3 Ϯ 0.04 mmol/h/kg body weight. The infusion was continued (a) for the time indicated up to 6 h, or (b) for a fixed period of 3.1 Ϯ 0.18 h, followed by 14 NH 4 Cl infusion at the same rate for Յ3.2 h (chase period). In Group II, 15 NH 4 Cl (2 M) was infused at a rate of 3.3 Ϯ 0.07 mmol/h/kg for Յ6 h. In this group, ammonia concentration was increased to 2 M to keep the infusate volume below 1 ml/h.
NMR-In vivo and in vitro
15N NMR spectra were obtained on a General Electric CSI-II spectrometer operating at 20.25 MHz for 15 N, as described previously (19,20).
15N chemical shifts are reported in ppm from nitromethane, with the negative sign indicating an upfield shift.